Business
AstraZeneca vaccine: Two more countries restrict vaccine rollout over blood clot concerns – The Australian Financial Review
An arm’s length investigation is needed to sort out the blood clot issue plaguing the AstraZeneca vaccine, say medical experts.
It also applied to those with heparin-induced thrombocytopenia, who have an adverse immune reaction to the drug heparin and their platelet function is affected.
ATAGI reassured people there was no evidence of risk for those with a history of other clotting conditions and recommended the jabs for a list for conditions including deep venous thrombosis, a clot in the lung and low platelets.
The vaccine was also recommended for people with risk factors for clotting: such as smoking or using oral contraceptives;…
-
Noosa News19 hours agoGippsland livestock agent Nathan Gibbon jailed for defrauding exporting companies
-
Noosa News19 hours agoTax office launches probe into case with devastating outcome
-
Noosa News22 hours agoCommonwealth Bank executive Christopher James McCann gets bail after being charged with grooming girls for sex
-
Business22 hours agoHow I’m preparing my ASX earnings season watchlist